Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells-Reference-Cited by-同舟云学术

Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells

Published:2021-12-28 Issue: Volume: Page:
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Di Paola Alessandra¹,Palumbo Giuseppe²,Tortora Chiara³,Argenziano Maura³,Catanoso Marialuigia²,Di Leva Caterina³,Ceglie Giulia²^ORCID,Perrotta Silverio³,Locatelli Franco²^ORCID,Rossi Francesca³^ORCID

Affiliation:

1. Department of Experimental Medicine University of Campania “Luigi Vanvitelli” Naples Italy

2. Department of Haematology Bambino Gesù Hospital Rome Italy

3. Department of Woman, Child and General and Specialist Surgery University of Campania “Luigi Vanvitelli” Naples Italy

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18012

Reference33 articles.

1. Immune Thrombocytopenia

2. Use of eltrombopag for secondary immune thrombocytopenia in clinical practice

3. Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia ( ITP ) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies

4. Management of immune thrombocytopenia in women: current standards and special considerations

5. Effects of Eltrombopag on In Vitro Macrophage Polarization in Pediatric Immune Thrombocytopenia

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of the HMGB1‐TLR4 pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia;British Journal of Haematology;2024-08-21

2. Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics;Hämostaseologie;2024-06-26

3. The long-term efficacy of eltrombopag in children with immune thrombocytopenia;Annals of Hematology;2024-06-25

4. The long-term efficacy of eltrombopag in children with immune thrombocytopenia;2024-04-25

5. Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial;Signal Transduction and Targeted Therapy;2024-04-23